We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Ulta Beauty
ULTA
$23.2B
| $8.24M | 0.02% |
54,641
+2,412
| +5% | +$334K |
|
|
ESL
602
DELISTED
Esterline Technologies
ESL
| $8.23M | 0.02% |
71,963
+2,733
| +4% | +$309K |
|
603
Omega Healthcare
OHI
$14.4B
| $8.21M | 0.02% |
202,378
+32,080
| +19% | +$1.33M |
|
604
American Financial Group
AFG
$11.7B
| $8.21M | 0.02% |
127,968
-13,692
| -10% | -$848K |
|
605
AptarGroup
ATR
$8.7B
| $8.14M | 0.02% |
128,164
+14,400
| +13% | +$926K |
|
606
Cadence Design Systems
CDNS
$94.1B
| $8.1M | 0.02% |
439,249
+33,895
| +8% | +$617K |
|
607
NVR
NVR
$16.6B
| $8.05M | 0.02% |
6,056
+393
| +7% | +$514K |
|
|
MXIM
608
DELISTED
Maxim Integrated Products
MXIM
| $8.04M | 0.02% |
231,107
+6,200
| +3% | +$212K |
|
609
Community Health Systems
CYH
$412M
| $8.04M | 0.02% |
186,028
+17,158
| +10% | +$710K |
|
610
Arrow Electronics
ARW
$11.5B
| $8.03M | 0.02% |
131,255
+10,449
| +9% | +$622K |
|
611
NNN REIT
NNN
$8.93B
| $8.02M | 0.02% |
195,780
+15,775
| +9% | +$654K |
|
612
Ingredion
INGR
$6.37B
| $8.01M | 0.02% |
102,933
+6,949
| +7% | +$569K |
|
|
WDR
613
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $7.97M | 0.02% |
160,892
+42,594
| +36% | +$2.04M |
|
614
Allegion
ALLE
$13.7B
| $7.95M | 0.02% |
129,962
+915
| +0.7% | +$52.3K |
|
615
Jazz Pharmaceuticals
JAZZ
$15.8B
| $7.94M | 0.02% |
45,977
+1,736
| +4% | +$298K |
|
616
Steris
STE
$22.6B
| $7.92M | 0.02% |
112,664
+15,368
| +16% | +$1.01M |
|
617
Tyler Technologies
TYL
$12.5B
| $7.89M | 0.02% |
65,475
+8,814
| +16% | +$1.01M |
|
|
WIN
618
DELISTED
Windstream Holdings Inc
WIN
| $7.88M | 0.02% |
135,998
+20,165
| +17% | +$1.29M |
|
619
Flowers Foods
FLO
$1.53B
| $7.88M | 0.02% |
346,629
+25,306
| +8% | +$525K |
|
620
East-West Bancorp
EWBC
$18.1B
| $7.87M | 0.02% |
194,493
+15,890
| +9% | +$622K |
|
|
TRW
621
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $7.85M | 0.02% |
74,842
+503
| +0.7% | +$52.2K |
|
|
TCO
622
DELISTED
Taubman Centers Inc.
TCO
| $7.83M | 0.02% |
101,576
+7,909
| +8% | +$623K |
|
623
Lamar Advertising Co
LAMR
$16B
| $7.82M | 0.02% |
131,989
+19,770
| +18% | +$1.13M |
|
|
GAS
624
DELISTED
AGL Resources Inc
GAS
| $7.8M | 0.02% |
157,041
-14,883
| -9% | -$773K |
|
625
WEX
WEX
$6.4B
| $7.79M | 0.02% |
72,545
+8,819
| +14% | +$890K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.